Adoption of rimegepant in Denmark: a register-based study on uptake, prescribing patterns and initiator characteristics
The study highlights the rapid uptake of rimegepant in Denmark, especially among middle-aged females with a history of triptan use and medication overuse. While rimegepant was associated with a reduction in acute medication overuse, early discontinuation rates suggest barriers to sustained use, potentially influenced by cost, efficacy, or patient preferences. There is a need for strategies to optimize long-term adherence and access to rimegepant in clinical practice.
Authors
- Lanfranco Pellesi (ORCID: https://orcid.org/0000-0003-4137-5039)
- Martin Ernst (ORCID: https://orcid.org/0000-0001-9003-3823)
- Thien Phu (ORCID: https://orcid.org/0009-0002-3662-5582)
- Anton Pottegård (ORCID: https://orcid.org/0000-0001-9314-5679)
- Jesper Hallas (ORCID: https://orcid.org/0000-0002-8097-8708)
Institutions
- University of Southern Denmark (DK)
- Herlev Hospital (DK)
- Glostrup Hospital (DK)
- Copenhagen University Hospital (DK)
- Gentofte Hospital (DK)
Publication Details
- Journal
- The Journal of Headache and Pain
- Published
- 2025-04-18
- DOI
- https://doi.org/10.1186/s10194-025-02028-w
- Citations
- 6
- Primary Topic
- Maternal Mental Health During Pregnancy and Postpartum
- Type
- article
- Field-Weighted Citation Impact
- 11.27